• 作者：E. Monteagudo^a ; ^{emonteagudo@aehh.org} ; R. Ferná ; ndez-Delgado^b ; A. Sastre^c ; T. Toll^d ; A. Llort^e ; J. Molina^f ; I. Astigarraga^g ; M.A. Dasí ; ^a ; A. Cervera^h ; en representació ; n del Grupo de Trabajo de la PTI de la Sociedad Espa&ntilde ; ola de Hematolog&iacute ; a y Oncolog&iacute ; a Pediá ; tricas
• 关键词：PTI ; Pú ; rpura trombocitopé ; nica inmune ; Trombocitopenia inmune primaria ; Infancia
• 刊名：Anales de Pediatr铆a
• 出版年：2011
• 期刊代码：pca47_16954033
• 类别：med
• 出版时间：June 2011
• 卷：74
• 期：6
• 页码：414.e1-414.e8
• 文件大小：229 K

Primary immune thrombocytopenia (ITP), formerly known as immune thrombocytopenic purpura, is a disease in which clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of ITP in children based on current guidelines, literature review, clinical trials and member consensus. The primary objective was to lessen clinical variability in diagnostic and therapeutic procedures in order to obtain best clinical results with minimal adverse events and good quality of life.